Merck’s ‘3 Is Key’ Campaign Goes Viral The drugmaker is urging docs to distribute a spiffy new brochure after administering the HPV vaccine in hopes teens and women will return for their second and third shots. However, the brochure, which is part of Merck’s ‘3 Is Key’ … [Read more...] about Merck To Text Teens About Gardasil Reminders?
Merck
The HPV Vaccine Public Relations Drum Beat Goes On
My Vaccine is Better than Your Vaccine” Merck and Glaxo PR hacks continue to deluge all media with “My Vaccine is Better than Your Vaccine” commercial jingles, youtube videos, interviews, dueling scientific papers, and lobby bucks, lots and lots of lobby bucks. It's no … [Read more...] about The HPV Vaccine Public Relations Drum Beat Goes On
Merck’s Post-Vioxx comeback
Stock Spotlight: Merck has had a Lazarus-like turn-around thanks to cost-cutting, new products and a savvy legal strategy. Is it still a buy? NEW YORK (CNNMoney.com) -- Merck has enjoyed a strong comeback since the messy Vioxx blowout nearly three years ago. But you might be … [Read more...] about Merck’s Post-Vioxx comeback
Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market
Glaxo Still Chasing FDA Approval For Cervarix The FDA’s approval for the ‘other’ HPV-vaccine, Cervarix is still delayed. GlaxoSmithKline, the world's second-largest drugmaker, requested a 'priority' review, potentially prompting an approval decision and sale of the Cervarix … [Read more...] about Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market
Merck’s Lybrand Plays It Cool In Midst Of Hot Controversy
News Analysis From BrandWeek Red flags raised by parents, politicians over Gardasil STD vaccine. To hear Beverly Lybrand tell it, you would not know she's a brand manager in the midst of a storm—over sex, teen girls, sexually transmitted diseases and cancer—that is currently … [Read more...] about Merck’s Lybrand Plays It Cool In Midst Of Hot Controversy